Jennifer L. Curnow

Westmead, NSW, Australia

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 66 publications

100 Years of von Willebrand Disease: The Journey to Contemporary Diagnostic Pathways-An Illustrative Case-Based Narrative Review.

100 Years of von Willebrand Disease: The Journey to Contemporary Diagnostic Pathways-An Illustrative Case-Based Narrative Review.

Journal: Seminars in thrombosis and hemostasis

Published: March 25, 2026

Laboratory Assessment of Factor VIII Inhibitors: When Is It Required? A Perspective Informed by Local Practice.

Laboratory Assessment of Factor VIII Inhibitors: When Is It Required? A Perspective Informed by Local Practice.

Journal: Journal of clinical medicine

Published: November 26, 2024

Current and emerging therapies as potential treatment for people with von Willebrand disease.

Current and emerging therapies as potential treatment for people with von Willebrand disease.

Journal: Expert review of hematology

Published: November 12, 2024

2025 Guidelines for direct oral anticoagulants: a practical guidance on the prescription, laboratory testing, peri-operative and bleeding management.

2025 Guidelines for direct oral anticoagulants: a practical guidance on the prescription, laboratory testing, peri-operative and bleeding management.

Journal: Internal medicine journal

Published: September 30, 2024

Ibrutinib plus rituximab and mini-CHOP in older patients with newly diagnosed DLBCL: a phase 2 ALLG study.

Ibrutinib plus rituximab and mini-CHOP in older patients with newly diagnosed DLBCL: a phase 2 ALLG study.

Journal: Blood advances

Published: June 20, 2024

Anticoagulation Strategies in Non-Critically Ill Patients with Covid-19.

Anticoagulation Strategies in Non-Critically Ill Patients with Covid-19.

Journal: NEJM evidence

Published: February 06, 2024

Efficacy and safety of avatrombopag in combination with immunosuppressive therapy in treatment-naïve and relapsed/refractory severe aplastic anaemia: protocol for the DIAAMOND-Ava-FIRST and DIAAMOND-Ava-NEXT Bayesian Optimal Phase II trials.

Efficacy and safety of avatrombopag in combination with immunosuppressive therapy in treatment-naïve and relapsed/refractory severe aplastic anaemia: protocol for the DIAAMOND-Ava-FIRST and DIAAMOND-Ava-NEXT Bayesian Optimal Phase II trials.

Journal: BMJ open

Published: January 18, 2024

Measurable Residual Disease (MRD) by Flow Cytometry in Adult B-Acute Lymphoblastic Leukaemia (B-ALL) and Acute Myeloid Leukaemia (AML): Correlation with Molecular MRD Testing and Clinical Outcome at One Year.

Measurable Residual Disease (MRD) by Flow Cytometry in Adult B-Acute Lymphoblastic Leukaemia (B-ALL) and Acute Myeloid Leukaemia (AML): Correlation with Molecular MRD Testing and Clinical Outcome at One Year.

Journal: Cancers

Published: September 15, 2023

Pulmonary embolism response teams. A description of the first 36-month Australian experience.

Pulmonary embolism response teams. A description of the first 36-month Australian experience.

Journal: Internal medicine journal

Published: September 03, 2023

Indeterminate measurable residual disease by multiparameter flow cytometry is associated with an intermediate risk of clinical relapse in adult patients with acute leukaemia.

Indeterminate measurable residual disease by multiparameter flow cytometry is associated with an intermediate risk of clinical relapse in adult patients with acute leukaemia.

Journal: Pathology

Published: August 26, 2023

Direct oral anticoagulants or vitamin K antagonists in emergencies: comparison of management in an observational study.

Direct oral anticoagulants or vitamin K antagonists in emergencies: comparison of management in an observational study.

Journal: Research and practice in thrombosis and haemostasis

Published: December 04, 2022

Vaccine-induced immune thrombotic thrombocytopenia post dose 2 ChAdOx1 nCoV19 vaccination: Less severe but remains a problem.

Vaccine-induced immune thrombotic thrombocytopenia post dose 2 ChAdOx1 nCoV19 vaccination: Less severe but remains a problem.

Journal: Vaccine

Published: November 23, 2022

Showing 1-12 of 66

Last Updated: 09/26/2026